Audicus Omni 2 vs Otofonix Encore

The Audicus Omni 2 is a premium-priced behind-the-ear OTC hearing aid available for $1,898. With a SoundScore of 4.6/5 and an A grade, it ranks #5 among 65 OTC hearing aids tested, placing it in the top 6% of its category. In our lab testing, the Omni 2 demonstrates strong speech clarity in quiet environments, scoring 4.2/5—well above the category average by 1.38 points. Speech in noise performance is more modest at 2.3/5, which is above the category average by 0.79 points but mixed in absolute terms. This pattern suggests the device handles everyday conversations well while challenging listening situations may still present difficulty. Music streaming is a particular strength, scoring 3.6/5 and exceeding the category average by a substantial 1.68 points. Feedback handling is excellent at 4.5/5, virtually matching the category average. Own-voice comfort scores a solid 3.0/5, which is 0.49 points above average for OTC devices. The Omni 2 offers both rechargeable and disposable battery options, along with streaming compatibility for iPhone and Android devices with hands-free capability. It has earned Expert's Choice Awards for both 2023 and 2024. Consumers seeking alternatives in this price range may also consider the similarly-priced Lucid Tala, while the lower-priced Lexie B3 offers competitive performance for those with tighter budgets.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.